跳至主要内容
临床试验/NCT00213473
NCT00213473已完成不适用

Prospective Clinical and Biological Follow-up of Acquired Haemophilia : SACHA Study

University Hospital, Rouen1 个研究点 分布在 1 个国家目标入组 81 人开始时间: 2001年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
81
试验地点
1

研究概览

简要总结

the aims of SACHA study was to appreciate prevalence, evolution and follow-up, treatment response of patients with acquired hemophilia with biological and clinical data. Inclusion criteria were factor VIIIc below 30% associated with presence of Facgteur VIII inhibitor (titer > 1 u Bethesda. Clinical and biologival data were obtained at Day 0 (as soon as possible and at 1, 3, 6 and 12 months.Informations were notified to co-investigators with the help of two french medical society (Internal medicine, french haemostasis and thrombosis society.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Factor VIIIc < 30% and Factor VIII inhibitor > 1 u Bethesda

排除标准

  • absence and signed consent, haemophilia A

研究者

发起方
University Hospital, Rouen
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验